FDA, Sensato and H-ISAC created the network to ensure that essential medical device and healthcare cybersecurity vulnerability information can be shared with all stakeholders across the healthcare and public health sector.
RED BANK, N.J. (PRWEB) October 09, 2018
Through the agreement, the FDA, H-ISAC, and Sensato-ISAO will create a mechanism for information about cybersecurity vulnerabilities and threats to be shared, along with critical best practices and other intelligence and guidance related to medical device cybersecurity.
MEDICAL DEVICE CYBERSECURITY: STATISTICS
The FDA learned of MDCTF's progress and assigned MITRE (the nonprofit that manages federally funded research and development centers supporting several U.S. government agencies) to the task force as its representative.
"We are so honored that MITRE approached us to consider evolving the MDCTF to an ISAO and formally partnering with the FDA and H-ISAC," says Sensato CEO John Gomez. "More than ever before, medical devices are being targeted and we need to be nimble and proactive in how we protect them and the patients they serve."
This partnership to advance education and critical intelligence in the healthcare industry aligns with Sensato's mission of proactive, comprehensive cybersecurity protection for healthcare and other critical infrastructure enterprises.
Sensato's signature cybersecurity solution, Nightingale, provides a next-generation layer of protection for enterprises by delivering an advanced system of intrusion detection, forensic analysis, and countermeasures.
Visit http://www.sensato.co.
For the original version on PRWeb visit: https://www.prweb.com/releases/fda_partners_with_sensato_isao_and_h_isac_to_create_open_source_cybersecurity_intelligence_network_and_resource/prweb15824171.htm
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
